FDA: early efforts to prepare new drug labels 'not as good as we'd hoped'

"Not as good as we'd hoped" is the reaction by the FDA to early efforts by manufacturers to prepare Rx drug labels in conformance with the agency's new "content and format" requirements, in effect since publication of a final rule on the subject last summer.
You must be a registered member of MMM to post a comment.
close

Next Article in Legal/Regulatory

 

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.